EDGAR Filing Documents for 0001179110-15-007859

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-15-007859

Filing Date

2015-05-14

Accepted

2015-05-14 19:36:19

Documents

Period of Report

2015-05-12

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	3856
	Complete submission text file	0001179110-15-007859.txt		5291

Mailing Address C/O BELLEROPHON THERAPEUTICS 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 15864934

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770

Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations